Clinical Trials Browser

OTHER × Spondylarthritis × Etanercept × Clear all

NCT02364479 2019-12-19

Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein

Phase 4 Completed

Recurrence, Spondylarthritis